AMIX
Autonomix Medical, Inc. Common Stock
NASDAQ · Healthcare · Medical - Devices · US
$4.59
−1.92%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | — | — | — | — | — |
| Cost of Revenue | 3.0K | 12.0K | — | — | — |
| Gross Profit | (3.0K) | (12.0K) | — | — | — |
| Operating Expenses | |||||
| R&D Expense | 7.1M | 7.1M | 4.7M | 2.2M | 745.0K |
| SG&A Expense | 9.3M | 9.9M | 6.9M | 5.2M | 1.2M |
| General & Admin Expense | 9.3M | 9.9M | 6.9M | 5.2M | 1.2M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (2.0K) | (12.0K) | — | 4.6M | — |
| Total Operating Expenses | 16.4M | 17.0M | 11.6M | 12.0M | 2.0M |
| Cost and Expenses | 16.4M | 17.0M | 11.6M | 12.0M | 2.0M |
| Operating Income (EBIT) | (16.4M) | (17.0M) | (11.6M) | (12.0M) | (2.0M) |
| Non-Operating | |||||
| Interest Income | 278.0K | 319.0K | 354.0K | 127.0K | — |
| Interest Expense | — | — | 176.0K | 79.0K | — |
| Net Interest Income | 278.0K | 319.0K | 178.0K | 48.0K | — |
| Other Non-Op Income/Expense | 278.0K | 319.0K | 178.0K | (3.4M) | — |
| Non-Operating Income (excl Interest) | (207.0K) | — | (354.0K) | 3.3M | — |
| EBT (Pre-Tax Income) | (16.1M) | (16.7M) | (11.4M) | (15.4M) | (2.0M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (16.1M) | (16.7M) | (11.4M) | (15.4M) | (2.0M) |
| Earnings from Cont. Ops | (16.1M) | (16.7M) | (11.4M) | (15.4M) | (2.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (16.1M) | (16.7M) | (11.4M) | (15.4M) | (2.0M) |
| Per Share | |||||
| Basic EPS | ($46.49) | ($48.64) | ($135.65) | ($343.78) | ($44.48) |
| Diluted EPS | ($46.49) | ($48.64) | ($135.65) | ($343.78) | ($44.48) |
| Revenue Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 543685 | 343655 | 84115 | 44871 | 44747 |
| Diluted Shares Outstanding | 543685 | 343655 | 84115 | 44871 | 44747 |
| Profitability Metrics | |||||
| EBITDA | (16.2M) | (17.0M) | (11.1M) | (15.3M) | (2.0M) |
| D&A | 12.0K | 12.0K | 183.0K | 81.0K | — |
| EBIT | (16.2M) | (17.0M) | (11.2M) | (15.3M) | (2.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026